Diagnostic value of ASVS for insulinoma localization: A systematic review and meta-analysis


Autoři: Hao Wang aff001;  Ying Ba aff001;  Qian Xing aff001;  Run-Ce Cai aff001
Působiště autorů: Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China aff001
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0224928

Souhrn

Background

Previous studies on the diagnostic value of arterial calcium stimulation with hepatic venous sampling (ASVS) for the localization of insulinoma have reported inconsistent results. Here, we performed a meta-analysis of the relevant published studies.

Methods

PubMed, Embase, Web of Science, the Cochrane Library, and Wanfang Data were searched for studies on the diagnostic value of ASVS in insulinoma localization published up to May 2019. We calculated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and receiver operating characteristic (ROC) curve of ASVS in the localization of insulinoma.

Results

We included ten studies involving 337 patients in the study. The pooled sensitivity, specificity, PLR, and NLR were 0.93 (95% confidence interval [CI]: 0.83–0.97), 0.86 (95%CI: 0.75–0.93), 6.8(95%CI: 3.7–12.7), and 0.08 (95%CI: 0.03–0.19), respectively. The DOR was 84 (95%CI: 30–233), and the area under the ROC curve was 0.96 (95%CI: 0.94–0.97).The results of the heterogeneity of the studies (P = 0.00, I2 = 80.17) were calculated using forest plots of the DOR.

Conclusion

ASVS is of significant value in localization of insulinoma. If a qualitative diagnosis of insulinoma is definite and the imaging examination results are negative, ASVS should be performed to confirm the localization of insulinoma.

Klíčová slova:

Arteries – Diagnostic medicine – Insulin – Mesenteric arteries – Surgical and invasive medical procedures – Insulinoma – Radionuclide imaging


Zdroje

1. Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711–719. doi: 10.1016/s0025-6196(12)62083-7 1677058

2. Daggett PR, Goodburn EA, Kurtz AB, Le Quesne LP, Morris DV, Nabarro JD,et al. Is preoperative localization of insulinomas necessary? Lancet 1981;1(8218):483–486. doi: 10.1016/s0140-6736(81)91859-6 6110099

3. Ravi KL, Britton BJ. Surgical approach to insulinomas: are pre-operative localisation tests necessary? Ann R Coll Surg Engl. 2007;89(3):212–217. doi: 10.1308/003588407X179008 17394700

4. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg, 2006;93(3):264–275. doi: 10.1002/bjs.5280 16498592

5. Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH. Insulinoma experience from 1950 to 1995;West J Med. 1998;169(2):98–104. 9735690

6. Abboud Bassam, Boujaoude Joe. Occult sporadic insulinoma: Localization andsurgical strategy. World Gastroenter, 2008, 14(5):657–665.

7. Klaus K, Ahmed BS, Wolfgang S, Niederle B. The importance of preoperative localisation procedures in organic hyperinsulinism–Experience in 67 patients. WienKlin Wochenschr, 2004;11(116): 373–378.

8. Oberg Kjell, Eriksson EBarbro. Endocrine tumours of the pancreas. Best Practice & Research Clinical Gastroenterology, 2005;19: 753–775.

9. Kuzin NM, Egorov AV, Kondrashin SA, Lotov AN, Kuznetzov NS, Majorova JB. Preoperative and intraoperative topographic diagnosis of insulinomas. World J Surg. 1998;Jun;22(6):593–597. doi: 10.1007/s002689900440 9597934

10. Abboud B, Boujaoude J. Occult sporadic insulinoma: localization and surgical strategy. World J Gastroenterol, 2008;14: 657–665. doi: 10.3748/wjg.14.657 18205253

11. Jyotsna VP, Rangel N, Pal S, Seith A, Sahni P, Ammini AC. Insulinoma: Diagnosis and surgical treatment. Retrospective analysis of 31 cases. Indian J Gastroenterol. 2006; Sep-Oct; 25(5): 244–247. 17090842

12. Angeli E, Vanzulli A, Castrucci M, Venturini M, Sironi S, Zerbi A, et al. Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: a comparison with dynamic CT and angiography. Abdom Imaging. 1997; May-Jun;22(3):295–303. doi: 10.1007/s002619900193 9107654

13. Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, et al. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine. 2007; Jun;31(3):238–241. doi: 10.1007/s12020-007-0045-4 17906369

14. Glover JR, Shorvon PJ, Lees WR. Endoscopic ultrasound for localisation of islet cell Tumours. Gut. 1992; Jan;33(1):108–110. doi: 10.1136/gut.33.1.108 1310948

15. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009; Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 19621072

16. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol2003;3:25.

17. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006;6;9. doi: 10.1186/1471-2288-6-9 16519814

18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3): 177–188. doi: 10.1016/0197-2456(86)90046-2 3802833

19. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 9:1237–1256.

20. Deeks JJ, Higgins JPT, Altman DG. Analyzing data and undertaking meta- analyses. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford, UK: The Cochrane Collaboration: 2008; chap 9.

21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560. doi: 10.1136/bmj.327.7414.557 12958120

22. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326: 219. doi: 10.1136/bmj.326.7382.219 12543843

23. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58: 882. doi: 10.1016/j.jclinepi.2005.01.016 16085191

24. Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med. 1995; Aug 15;123(4):269–273. doi: 10.7326/0003-4819-123-4-199508150-00004 7611592

25. O'Shea D, Rohrer-Theurs AW, Lynn JA, Jackson JE, Bloom SR. Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab. 1996; Apr;81(4):1623–1627. doi: 10.1210/jcem.81.4.8636378 8636378

26. Defreyne L, König K, Lerch MM, Hesse UJ, Rottiers R, Feifel G, et al. Modified intra-arterial calcium stimulation with venous sampling test for preoperative localization of insulinomas.Abdom Imaging. 1998; May-Jun;23(3):322–331. doi: 10.1007/s002619900350 9569307

27. Jin ZY, Zhao P, Li XG, Pan J, Zhao YP, Cai lx, et al.Value of the calcium intra arterial stimulation test in preoperative locazation of insulinoma. Chin J Radiol, January 2002;vol 36,44–47.

28. Wiesli P, Brändle M, Pfammatter T, Zapf J, Spinas GA, Schmid C. Insulin determination by specific and unspecific immunoassays in patients with insulinoma evaluated by the arterial stimulation and venous sampling test. Eur J Endocrinol. 2004; Jul;151(1):123–126. doi: 10.1530/eje.0.1510123 15248832

29. Guettier JM, Kam A, Chang R, Skarulis MC, Cochran C, Alexander HR, et al. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. J Clin Endocrinol Metab. 2009; Apr;94(4):1074–1080. doi: 10.1210/jc.2008-1986 19190102

30. Druce MR, Muthuppalaniappan VM, O'Leary B, Chew SL, Drake WM, Monson JP, et al. Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. Eur J Endocrinol. 2010; May;162(5):971–978. doi: 10.1530/EJE-10-0056 20207727

31. Braatvedt G, Jennison E, Holdaway IM. Comparison of two low-dose calcium infusion schedules for localization of insulinomas by selective pancreatic arterial injection with hepatic venous sampling for insulin. Clin Endocrinol (Oxf). 2014; Jan;80(1): 80–84

32. Morera J, Guillaume A, Courtheoux P, Palazzo L, Rod A, Joubert M, et al. Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance. J Endocrinol Invest. 2016 Apr;39(4):455–463 doi: 10.1007/s40618-015-0406-4 26577133

33. Moreno MP, Alhambra-Expósito MR, Herrera-Martínez AD, Palomares-Ortega R, Zurera-Tendero L, Espejo Herrero JJ, et al. Arterial Calcium Stimulation with Hepatic Venous Sampling in the Localization Diagnosis of Endogenous Hyperinsulinism. Int J Endocrinol 2016;2016:4581094. Epub 2016 Oct 3. doi: 10.1155/2016/4581094 27795707

34. Tseng LM, Chen JY, Won JG, Tseng HS, Yang AH, Wang SE, et a1. The role of intra-arterial calcium stimulation test with hepatic venous sampling(IACS)in the management of occult insulinomas. Ann Surg Oncol, 2007;14: 2121–2127. doi: 10.1245/s10434-007-9398-4 17431724

35. Sung YM, Do YS, Lee MK, Shin SW, Liu WC, Choo SW, et al. Selective Intra-arterial Calcium stimulation with hepatic venous sampling for preoperative loalization of Insulinoma. Korean J Radiol. 2003 Apr-Jun;4(2):101–108. doi: 10.3348/kjr.2003.4.2.101 12845305

36. Thompson SM, Vella A, Thompson GB, Rumilla KM, Service FJ, Grant CS, et al. Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates insulinoma from nesidioblastosis. J Clin Endocrinol Metab. 2015 Nov;100(11):4189–4197 doi: 10.1210/jc.2015-2404 26312578

37. Pereira PL, Roche AJ, Maier GW, Huppert PE, Dammann F, Farnsworth CT, et al. Insulinoma and islet cell hyperplasia: value of the calcium intraarterial stimulation test when findings of other preoperative studies are negative. Radiology. 1998; Mar;206(3):703–709. doi: 10.1148/radiology.206.3.9494488 9494488

38. Christ E, Wild D, Forrer F, Brandle M, Sahli R, Clerici T,et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas.J Clin Endocrinol Metab. 2009 Nov;94(11):4398–4405 doi: 10.1210/jc.2009-1082 19820010

39. Sowa-Staszczak A, Pach D, Mikolajczak R, Macke H, Jabrocka-Hybel A, Stefańska A, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):524–531 doi: 10.1007/s00259-012-2299-1 23224740

40. Wild D, Christ E, Caplin ME, Kurzawinski TR, Forrer F, Brandle M, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med. 2011 Jul;52(7):1073–1078 doi: 10.2967/jnumed.110.085142 21680696

41. Luo Y, Pan Q, Yao S, Yu M, Wu W, Xue H, et al. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study. J Nucl Med. 2016 May;57(5):715–720 doi: 10.2967/jnumed.115.167445 26795291


Článek vyšel v časopise

PLOS One


2019 Číslo 11